Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165

Growth Factors

Volumn 26, Issue 3, 2008, Pages 125-131

  Zhang, Yan ^a   Furumura, Minao ^a   Morita, Eishin ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Cell proliferation; HUVEC; Signaling pathway; Vascular permeability; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; VASCULOTROPIN 121; VASCULOTROPIN 165;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; PERMEABILITY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 46249092224     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802105909     Document Type: Article

References (27)

1. Bates, DO and Harper, SJ (2002) Regulation of vascular permeability by vascular endothelial growth factors. Vasc Pharmacol, 39, pp. 225-237.
2. Braverman, IM and Sibley, J. (1982) Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol, 78, pp. 12-17.
3. Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, HW, McKay, P., de Vos, AM and Lowman, HB (1999) Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen. J Mol Biol, 293, pp. 865-881.
4. Eliceiri, BP, Paul, R., Schwartzberg, PL, Hood, JD, Leng, J. and Cheresh, DA (1999) Selective requirement for Src kinases during VEGF-induced angiogensis and vascular permeability. Mol Cell, 4, pp. 915-924.
5. Eliceiri, BP, Puente, XS, Hood, JD, Stupack, DG, Schlaepfer, DD, Huang, XZ, Sheppard, D. and Cheresh, DA (2002) Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol, 157, pp. 149-160.
6. Ferrara, N., Gerber, HP and LeCouter, J. (2003) The biology of VEGF and its receptors. Nat Med, 9, pp. 669-676.
7. Gavard, J. and Gutkind, JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol, 8, pp. 1223-1234.
8. Grunstein, J., Masbad, JJ, Hickey, R., Giordano, F. and Johnson, RS (2000) Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol, 20, pp. 7282-7291.
9. Ilan, N., Mahooti, S. and Madri, JA (1998) Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci, 111, pp. 3621-3631.
10. Issbrucker, K., Marti, HH, Hippenstiel, S., Springmann, G., Voswinckel, R., Gaumann, A., Breier, G., Drexler, HC, Suttorp, N. and Clauss, M. (2003) p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J, 17, pp. 262-264.
11. Keyt, BA, Berleau, LT, Nguyen, HV, Chen, H., Heinsohn, H., Vandlen, R. and Ferrara, N. (1996) The carboxyl-terminal domain (111 - 165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem, 271, pp. 7788-7795.
12. Kilic, E., Kilic, U., Wang, Y., Bassetti, CL, Marti, HH and Hermann, DM (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J, 20, pp. 1185-1187.
13. Küsters, B., de Waal, RM, Wesseling, P., Verrijp, K., Maass, C., Heerschap, A., Barentsz, JO, Sweep, F., Ruiter, DJ and Leenders, WP (2003) Differential effects of vascular endothelial growth factor A isoforms in a mouse brain metastasis model of human melanoma. Cancer Res, 63, pp. 5408-5413.
14. Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, Z. (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 13, pp. 9-22.
15. Olsson, AK, Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol, 7, pp. 359-371.
16. Ruckman, J., Green, LS, Beeson, J., Waugh, S., Gillette, WL, Henninger, DD, Claesson-Welsh, L. and Janjic, N. (1998) 2′-fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem, 273, pp. 20556-20567.
17. Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C. and Shima, DT (2002) Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev, 16, pp. 2684-2698.
18. Takahashi, H. and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci, 109, pp. 227-241.
19. Takahashi, T., Yamaguchi, S., Chida, K. and Shibuya, M. (2001) A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J, 20, pp. 2768-2778.
20. Weis, S., Shintani, S., Weber, A., Kirchmair, R., Wood, M., Cravens, A., McSharry, H., Iwakura, A., Yoon, YS Himes, N. et al. (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest, 113, pp. 885-894.
21. Whitaker, GB, Limberg, BJ and Rosenbaum, JS (2001) Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121. J Biol Chem, 276, pp. 25520-25531.
22. Xia, P., Aiello, LP, Ishii, H., Jiang, ZY, Park, DJ, Robinson, GS, Takagi, H., Newsome, WP, Jirousek, MR and King, GL (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its Isoform, and endothelial cell growth. J Clin Invest, 98, pp. 2018-2026.
23. Yu, JL, Rak, JW, Klement, G. and Kerbel, RS (2002) Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Res, 62, pp. 1838-1846.
24. Zachary, I. (2003) VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem Soc Trans, 31, pp. 1171-1177.
25. Zhang, HT, Scott, PA, Morbidelli, L., Peak, S., Moore, J., Turley, H., Harris, AL, Ziche, M. and Bicknell, R. (2000) The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer, 83, pp. 63-68.
26. Zhang, Y., Matsuo, H. and Morita, E. (2005) Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales. Exp Dermatol, 14, pp. 758-764.
27. Zhang, Y., Matsuo, H. and Morita, E. (2006) Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch Dermatol Res, 297, pp. 425-429.